EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Focal 18 F‐FDG uptake predicts progression of pre‐invasive squamous bronchial lesions to invasive cancers

Illaa Smesseim iD, Robert A van Boerdonk, Chris Dickhoff, David J Heineman, Max R Dahele, Teodora Radonic, Idris Bahce, Simone P Rauh, Emile F I Comans, Hans J M A Daniels

Thoracic Cancer · 2023-03 · 14 (9) · 840-847

DOI: 10.1111/1759-7714.14815 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Thoracic Cancer, online erschienen am 18.02.2023. Verfasst von Illaa Smesseim und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pulmonary Diseases, Amsterdam University Medical Center, Location Free University Medical Center, Amsterdam, The Netherlands. Hauptthemen laut MEDLINE: Lung Neoplasms, Carcinoma, Squamous Cell. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Pre‐invasive squamous lesions of the central airways can progress into invasive lung cancers. Identifying these high‐risk patients could enable detection of invasive lung cancers at an early stage. In this study, we investigated the value of 18 F‐fluorodeoxyglucose ( 18 F‐FDG) positron emission tomography (PET) scans in predicting progression in patients with pre‐invasive squamous endobronchial lesions.

Methods

In this retrospective study, patients with pre‐invasive endobronchial lesions, who underwent an 18 F‐FDG PET scan at the VU University Medical Center Amsterdam, between January 2000 and December 2016, were included. Autofluorescence bronchoscopy (AFB) was used for tissue sampling and was repeated every 3 months. The minimum and median follow‐up was 3 and 46.5 months. Study endpoints were the occurrence of biopsy proven invasive carcinoma, time‐to‐progression and overall survival (OS).

Results

A total number of 40 of 225 patients met the inclusion criteria of which 17 (42.5%) patients had a positive baseline 18 F‐FDG PET scan. A total of 13 of 17 (76.5%) developed invasive lung carcinoma during follow‐up, with a median time to progression of 5.0 months (range, 3.0–25.0). In 23 (57.5%) patients with a negative 18 F‐FDG PET scan at baseline, 6 (26%) developed lung cancer, with a median time to progression of 34.0 months (range, 14.0–42.0 months, p < 0.002). With a median OS of 56.0 months (range, 9.0–60.0 months) versus 49.0 months (range, 6.0–60.0 months) ( p = 0.876) for the 18 F‐FDG PET positive and negative groups, respectively.

Conclusions

Patients with pre‐invasive endobronchial squamous lesions and a positive baseline 18 F‐FDG PET scan were at high‐risk for developing lung carcinoma, highlighting that this patient group requires early radical treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lung NeoplasmsCarcinoma, Squamous CellHumansFluorodeoxyglucose F18Retrospective StudiesPositron-Emission Tomography

Stichwörter der Autor:innen

PET-scanendobronchiallung cancerlung carcinomapre-invasive lesions

Substanzen

Fluorodeoxyglucose F18

Autor:innen und Institutionen

  • Department of Pulmonary Diseases, Amsterdam University Medical Center, Location Free University Medical Center, Amsterdam, The Netherlands.
  • Department of Pathology, Amsterdam University Medical Center, Amsterdam, The Netherlands.
  • Department of Cardiothoracic Surgery, Amsterdam University Medical Center, Amsterdam, The Netherlands.
  • Department of Radiotherapy, Amsterdam University Medical Center, Amsterdam, The Netherlands.
  • Department of Epidemiology and Biostatistics, Amsterdam University Medical Center, Amsterdam, The Netherlands.
  • Department of Radiology and Nuclear Medicine, Amsterdam University Medical Center, Amsterdam, The Netherlands.

ORCID-Profile: Illaa Smesseim

Zitieren

APA

Smesseim, I., van Boerdonk, R. A., Dickhoff, C., Heineman, D. J., Dahele, M. R., Radonic, T., Bahce, I., Rauh, S. P., Comans, E. F. I., & Daniels, H. J. M. A. (2023). Focal 18 F‐FDG uptake predicts progression of pre‐invasive squamous bronchial lesions to invasive cancers. Thoracic Cancer, 14(9), 840-847. https://doi.org/10.1111/1759-7714.14815

Vancouver

Smesseim I, van Boerdonk RA, Dickhoff C, Heineman DJ, Dahele MR, Radonic T, et al. Focal 18 F‐FDG uptake predicts progression of pre‐invasive squamous bronchial lesions to invasive cancers. Thoracic Cancer. 2023;14(9):840-847. doi:10.1111/1759-7714.14815

BibTeX
@article{Smesseim2023,
  author = {Smesseim, Illaa and van Boerdonk, Robert A and Dickhoff, Chris and Heineman, David J and Dahele, Max R and Radonic, Teodora and Bahce, Idris and Rauh, Simone P and Comans, Emile F I and Daniels, Hans J M A},
  title = {Focal 18 F‐FDG uptake predicts progression of pre‐invasive squamous bronchial lesions to invasive cancers},
  journal = {Thoracic Cancer},
  year = {2023},
  volume = {14},
  number = {9},
  pages = {840--847},
  doi = {10.1111/1759-7714.14815}
}
Kostenlos starten →